The global liquid biopsy market size stood at US$ 3.7 Bn in 2022 and is expected to increase at a CAGR of 8.8% from 2023 to 2031, reaching US$ 7.7 Bn by the end of 2031. The liquid biopsy market is rapidly transforming the global diagnostics and oncology landscape by offering minimally invasive solutions for cancer detection, monitoring, and treatment planning. Unlike traditional tissue...

The liver cancer diagnostics market is expected to reach US $ 2.81 billion, thanks to growth in the industrial product segment. The report analyzes Liver Cancer Diagnostics Market dynamics by region and end-user industries. liver cancer diagnostics market  Report Overview: The report comprehensively encompasses the analysis of insights concerning the   liver cancer...

The global molecular imaging market is experiencing significant growth, driven by advancements in imaging technologies, increased prevalence of chronic diseases, and a growing emphasis on personalized medicine. Molecular imaging, which allows for the visualization of biological processes at the molecular and cellular levels within living organisms, is becoming an indispensable tool in modern...

"Non-Small Cell Lung Cancer Diagnostics Market Summary: According to the latest report published by Data Bridge Market Research, the Non-Small Cell Lung Cancer Diagnostics Market  CAGR Value The global non-small cell lung cancer diagnostics market size was valued at USD 2.39 billion in 2025 and is expected to reach USD 6.44 billion by 2033, at a CAGR of...

" According to the latest report published by Data Bridge Market Research, the Non-Small Cell Lung Cancer Diagnostics Market CAGR Value The global non-small cell lung cancer diagnostics market size was valued at USD 2.39 billion in 2025 and is expected to reach USD 6.44 billion by 2033, at a CAGR of 13.20% during the forecast period Market...

The rapid evolution of cancer molecular diagnostics, increasing adoption of molecular diagnostics in oncology, and growing demand for precision oncology diagnostics are transforming cancer detection and treatment worldwide. Molecular diagnostic technologies enable healthcare professionals to identify genetic mutations, biomarkers, and tumor-specific molecular...

The increasing prevalence of gastric cancer and the growing emphasis on early disease detection are driving significant advancements in gastric cancer diagnostics, stomach cancer diagnosis, and innovative gastric cancer biomarkers. Early identification of gastric cancer plays a crucial role in improving treatment outcomes, enabling timely intervention, and supporting personalized treatment...

The cancer biomarkers market is entering a period of strong expansion as rising cancer cases, increasing emphasis on early diagnosis, and growing adoption of personalized treatment continue to reshape oncology care. According to Grand View Research, the market size was valued at USD 26.9 billion in 2025 and is projected to increase from USD 29.9 billion in 2026 to USD 65.3 billion by 2033,...